Don't Miss STAT Staff As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies
Special Report Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
Special Report Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Don't Miss STAT STAT Madness 2020 voting ends tonight. Cast your vote for the best innovations in biomedicine
Don't Miss STAT Staff STAT Plus: What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Don't Miss Alissa Ambrose ‘You keep loving each other’: A window into dementia at the end of a lifelong partnership
Don't Miss Sharon Begley What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets
Don't Miss Rebecca Robbins With time ticking away, clinicians scramble to save newborn twins from the disease that took their brother
Don't Miss Eric Boodman Font of despair: In the fierce competition for science funding, even a typeface glitch can be fatal
Don't Miss Helen Branswell, Adam Feuerstein, and Damian Garde STAT Plus: BIO in 30: A new biotech from Gates, Bradner on data science, & bienvenue à Cambridge
Don't Miss Damian Garde and Rebecca Robbins BIO in 30: The mechanics of drug prices, a new world record, & a very Canadian table hockey game